Last quarter (Q0 0), Nirvana Life Sciences Inc's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Nirvana Life Sciences Inc's net income was $-61.10K. See Nirvana Life Sciences Inc’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Apr 24	Apr 23	Apr 22	Oct 21
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ ―
Cost of Revenue	$ 18.31K	$ 18.31K	$ ―	$ ―	$ ―
Gross Profit	$ -18.31K	$ -18.31K	$ ―	$ ―	$ ―
Operating Expense	$ 459.27K	$ 725.70K	$ 1.25M	$ 5.35M	$ 333.73K
Operating Income	$ -477.58K	$ -744.01K	$ -1.25M	$ -5.35M	$ -333.73K
Net Non Operating Interest Income Expense	$ ―	$ -665.00	$ -8.34K	$ 12.34K	$ ―
Other Income Expense	$ -18.31K	$ 128.69K	$ 232.66K	$ 319.48K	$ 79.25K
Pretax Income	$ -459.27K	$ -873.36K	$ -1.49M	$ -5.66M	$ -254.47K
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -458.25K	$ -871.82K	$ -1.49M	$ -5.65M	$ -254.47K
Basic EPS	$ -0.01	$ -0.02	$ -0.04	$ -0.16	$ -0.01
Diluted EPS	$ -0.01	$ -0.02	$ -0.04	$ -0.16	$ -0.01
Basic Average Shares	$ 193.04M	$ 46.71M	$ 33.94M	$ 36.52M	$ 33.02M
Diluted Average Shares	$ 193.04M	$ 46.71M	$ 33.94M	$ 36.52M	$ 33.02M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 477.58K	$ 744.01K	$ 1.25M	$ 5.35M	$ -333.73K
Net Income From Continuing And Discontinued Operation	$ -458.25K	$ -871.82K	$ -1.49M	$ -5.65M	$ -254.47K
Normalized Income	$ -385.49K	$ -485.24K	$ -845.23K	$ -4.16M	$ -197.29K
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -459.27K	$ -872.70K	$ -1.48M	$ -5.66M	$ -254.47K
EBITDA	$ -440.96K	$ -854.38K	$ -1.39M	$ -5.57M	$ -254.47K

Currency in USD

Nirvana Life Sciences Inc Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing